Improvement in Lipids after Switch to Boosted Atazanavir or Darunavir in Children/Adolescents with Perinatally Acquired HIV on Older Protease Inhibitors: Results from the Pediatric HIV/AIDS Cohort Study

BACKGROUND: Dyslipidemia is common in perinatally HIV-infected (PHIV) youth receiving Protease Inhibitors (PIs). Few studies have evaluated longitudinal lipid changes in PHIV youth after switch to newer PIs. METHODS: We compared longitudinal changes in fasting lipids [Total Cholesterol (TC), Triglyc...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :HIV Med
Главные авторы: Jao, Jennifer, Yu, Wendy, Patel, Kunjal, Miller, Tracie L., Karalius, Brad, Geffner, Mitchell E., DiMeglio, Linda A., Mirza, Ayesha, Chen, Janet S., Silio, Margarita, McFarland, Elizabeth J., Van Dyke, Russell B., Jacobson, Denise
Формат: Artigo
Язык:Inglês
Опубликовано: 2017
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5821593/
https://ncbi.nlm.nih.gov/pubmed/29159965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12566
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы